retatrutide phase 2 nejm weight loss 48 weeks 2023 percent Retatrutide (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the GLP1 drugs. https://www.nejm .org/doi/full/10.1056/NEJMoa2301972 Retatrutide vs Tirzepatide Compared |

Most side effects, such as mild nausea, bloating, or fatigue, are temporary and typically resolve within one to three weeks as your body adjusts to the medication

Phase 3 trials are the key stage for FDA approval

All laboratory personnel must follow proper research protocols, chemical handling guidelines, and institutional ethics rules.

The glucagon receptor is associated with thermogenesis and energy expenditure, which is a mechanism not engaged by either semaglutide or tirzepatide

Aesthetics: Losing facial fat + losing facial muscle = the gaunt look often called Ozempic Face. Longevity: For our older readers, muscle is the organ of longevity

Hard endpoints are actual clinical events like heart attacks, strokes, and deaths